Registry Study for Patients Diagnosed with Hyperparathyroidism or Hypoparathyroidism Long-term Monitoring of Biochemical, Clinical, Radiological, and Histological Data

What this Trial Is About

Researchers are establishing a registry to include all patients diagnosed with parathyroid diseases such as hyperparathyroidism or hypoparathyroidism who have been evaluated at the Endocrinology Operating Unit. The goal is to collect and study biochemical, clinical, radiological, medico-nuclear, and histological data over a long period to better understand these conditions. This observational study spans 30 years, enrolling patients seen from January 1, 2000, to December 31, 2029. The registry will track patients through at least two endocrinology visits to confirm diagnosis and consent. Data collection includes biochemical tests, clinical symptom monitoring, imaging studies, and histopathological evaluations. Follow-up for each patient is expected to last about 10 years, with continuous updates until the registry closes at the end of 2039. Participants will be observed over time with regular assessments of biochemical markers, clinical symptoms, imaging results, and tissue characteristics related to parathyroid disorders. The research team will monitor these outcomes longitudinally to observe disease progression and related health effects. This study involves no treatment interventions, focusing on collecting comprehensive data to support future research efforts.

Establishment of a Registry of Patients With Parathyroid Disease